Histone Deacetylase (HDAC) Inhibitors with a Novel Connecting Unit Linker Region Reveal a Selectivity Profile for HDAC4 and HDAC5 with Improved Activity against Chemoresistant Cancer Cells
Citations Over TimeTop 11% of 2012 papers
Abstract
The synthesis and biological evaluation of new potent hydroxamate-based HDAC inhibitors with a novel alkoxyamide connecting unit linker region are described. Biological evaluation includes MTT and cellular HDAC assays on sensitive and chemoresistant cancer cell lines as well as HDAC profiling of selected compounds. Compound 19i (LMK235) (N-((6-(hydroxyamino)-6-oxohexyl)oxy)-3,5-dimethylbenzamide) showed similar effects compared to vorinostat on inhibition of cellular HDACs in a pan-HDAC assay but enhanced cytotoxic effects against the human cancer cell lines A2780, Cal27, Kyse510, and MDA-MB231. Subsequent HDAC profiling yielded a novel HDAC isoform selectivity profile of 19i in comparison to vorinostat or trichostatin A (TSA). 19i shows nanomolar inhibition of HDAC4 and HDAC5, whereas vorinostat and TSA inhibit HDAC4 and HDAC5 in the higher micromolar range.
Related Papers
- → The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes(2004)315 cited
- → Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo(1998)234 cited
- → Faculty Opinions recommendation of The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes.(2004)
- → Faculty Opinions recommendation of The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes.(2004)
- → Faculty Opinions recommendation of The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes.(2004)